SEC Filings

MEDTRONIC PLC filed this Form DEFR14A on 10/11/2017
Entire Document
(4) Includes 86 shares held by Ms. Parkhill’s trust.
(5) Includes 3,000 shares held by Mr. Powell’s spouse’s trust.
(6) Includes 24,700 shares owned jointly with Mr. Pozen’s spouse.
(7) As of July 7, 2017, no director or executive officer beneficially owns more than 1% of the shares outstanding. Medtronic’s directors and executive officers as a group beneficially own approximately .31% of the shares outstanding.
(8) Amounts include the shares shown in the last column, which are not currently outstanding but are deemed beneficially owned because of the right to acquire shares pursuant to options exercisable or RSUs vesting and payable within 60 days (on or before December 9, 2017) and the right to receive shares for deferred stock units within 60 days (on or before December 9, 2017) upon a director’s resignation.


Section 16(a) Beneficial Ownership Reporting Compliance


Based upon a review of reports and written representations furnished to it, Medtronic believes that during Fiscal Year 2017, all filings with the SEC by its executive officers and directors complied with requirements for reporting ownership and changes in ownership of Medtronic’s ordinary shares pursuant to Section 16(a) of the Exchange Act.


 MEDTRONIC PLC   2017 Proxy Statement   31